Showing 1 to 10 of 825 records(fetched in 2.698 seconds)
TitleThe Relation Between eHealth Literacy and Health-Related Behaviors: Systematic Review and Meta-analysis.
AuthorsKim, K; Shin, S; Kim, S; Lee, E
JournalJournal of medical Internet research
Publication Date30 Jan 2023
Date Added to PubMed31 Jan 2023
AbstractWith widespread use of the internet and mobile devices, many people have gained improved access to health-related information online for health promotion and disease management. As the health information acquired online can affect health-related behaviors, health care providers need to take into account how each individual's online health literacy (eHealth literacy) can affect health-related behaviors. To determine whether an individual's level of eHealth literacy affects actual health-related behaviors, the correlation between eHealth literacy and health-related behaviors was identified in an integrated manner through a systematic literature review and meta-analysis. The MEDLINE, Embase, Cochrane, KoreaMed, and Research Information Sharing Service databases were systematically searched for studies published up to March 19, 2021, which suggested the relationship between eHealth literacy and health-related behaviors. Studies were eligible if they were conducted with the general population, presented eHealth literacy according to validated tools, used no specific control condition, and measured health-related behaviors as the outcomes. A meta-analysis was performed on the studies that could be quantitatively synthesized using a random effect model. A pooled correlation coefficient was generated by integrating the correlation coefficients, and the risk of bias was assessed using the modified Newcastle-Ottawa Scale. Among 1922 eHealth literacy-related papers, 29 studies suggesting an association between eHealth literacy and health-related behaviors were included. All retrieved studies were cross-sectional studies, and most of them used the eHealth Literacy Scale (eHEALS) as a measurement tool for eHealth literacy. Of the 29 studies, 22 presented positive associations between eHealth literacy and health-related behaviors. The meta-analysis was performed on 14 studies that presented the correlation coefficient for the relationship between eHealth literacy and health-related behaviors. When the meta-analysis was conducted by age, morbidity status, and type of health-related behavior, the pooled correlation coefficients were 0.37 (95% CI 0.29-0.44) for older adults (aged ≥65 years), 0.28 (95% CI 0.17-0.39) for individuals with diseases, and 0.36 (95% CI 0.27-0.41) for health-promoting behavior. The overall estimate of the correlation between eHealth literacy and health-related behaviors was 0.31 (95% CI 0.25-0.34), which indicated a moderate correlation between eHealth literacy and health-related behaviors. Our results of a positive correlation between eHealth literacy and health-related behaviors indicate that eHealth literacy can be a mediator in the process by which health-related information leads to changes in health-related behaviors. Larger-scale studies with stronger validity are needed to evaluate the detailed relationship between the proficiency level of eHealth literacy and health-related behaviors for health promotion in the future.
Linkhttp://doi.org/10.2196/40778
TitleArtificial intelligence in the field of pharmacy practice: A literature review.
AuthorsChalasani, SH; Syed, J; Ramesh, M; Patil, V; Pramod Kumar, TM
JournalExploratory research in clinical and social pharmacy
Publication Date1 Dec 2023
Date Added to PubMed27 Oct 2023
AbstractArtificial intelligence (AI) is a transformative technology used in various industrial sectors including healthcare. In pharmacy practice, AI has the potential to significantly improve medication management and patient care. This review explores various AI applications in the field of pharmacy practice. The incorporation of AI technologies provides pharmacists with tools and systems that help them make accurate and evidence-based clinical decisions. By using AI algorithms and Machine Learning, pharmacists can analyze a large volume of patient data, including medical records, laboratory results, and medication profiles, aiding them in identifying potential drug-drug interactions, assessing the safety and efficacy of medicines, and making informed recommendations tailored to individual patient requirements. Various AI models have been developed to predict and detect adverse drug events, assist clinical decision support systems with medication-related decisions, automate dispensing processes in community pharmacies, optimize medication dosages, detect drug-drug interactions, improve adherence through smart technologies, detect and prevent medication errors, provide medication therapy management services, and support telemedicine initiatives. By incorporating AI into clinical practice, health care professionals can augment their decision-making processes and provide patients with personalized care. AI allows for greater collaboration between different healthcare services provided to a single patient. For patients, AI may be a useful tool for providing guidance on how and when to take a medication, aiding in patient education, and promoting medication adherence and AI may be used to know how and where to obtain the most cost-effective healthcare and how best to communicate with healthcare professionals, optimize the health monitoring using wearables devices, provide everyday lifestyle and health guidance, and integrate diet and exercise.
Linkhttp://doi.org/10.1016/j.rcsop.2023.100346
TitleeHealth and mHealth.
AuthorsMoss, RJ; Süle, A; Kohl, S
JournalEuropean journal of hospital pharmacy : science and practice
Publication Date1 Jan 2019
Date Added to PubMed4 Jun 2019
AbstractBoth electronic health (eHealth) and mobile health (mHealth) are becoming prominent components of healthcare. In order for healthcare electronic services to be safe and effective and add genuine value to the system, the European Association of Hospital Pharmacists (EAHP) believes that these should be developed in close collaboration with healthcare professionals including hospital pharmacists, and patients. Consequently, the EAHP calls in its position paper upon national governments and health systems across Europe to work towards (1) systematic and European Union-wide achievement of electronic prescribing, administration and use of electronic medical records; (2) ensuring barcoding of medicines to the single units in primary packages to enable more widespread take-up of bedside scanning in European hospitals, thus improving patient safety; (3) appropriate regulatory oversight mechanisms for mHealth applications to ensure that they have a positive impact and adequately protect patient data; (4) provision of appropriate eHealth/mHealth training opportunities to healthcare professionals and promotion of digital health literacy; and (5) involvement of hospital pharmacists in the design, specification of parameters and evaluation of information and communication technology within the medicines processes.
Linkhttp://doi.org/10.1136/ejhpharm-2018-001819
TitleFacilitators and Barriers to Chronic Disease Self-Management and Mobile Health Interventions for People Living With Diabetes and Hypertension in Cambodia: Qualitative Study.
AuthorsSteinman, L; Heang, H; van Pelt, M; Ide, N; Cui, H; Rao, M; LoGerfo, J; Fitzpatrick, A
JournalJMIR mHealth and uHealth
Publication Date24 Apr 2020
Date Added to PubMed25 Apr 2020
AbstractIn many low- and middle-income countries (LMICs), heart disease and stroke are the leading causes of death as cardiovascular risk factors such as diabetes and hypertension rapidly increase. The Cambodian nongovernmental organization, MoPoTsyo, trains local residents with diabetes to be peer educators (PEs) to deliver chronic disease self-management training and medications to 14,000 people with hypertension and/or diabetes in Cambodia. We collaborated with MoPoTsyo to develop a mobile-based messaging intervention (mobile health; mHealth) to link MoPoTsyo's database, PEs, pharmacies, clinics, and people living with diabetes and/or hypertension to improve adherence to evidence-based treatment guidelines. This study aimed to understand the facilitators and barriers to chronic disease management and the acceptability, appropriateness, and feasibility of mHealth to support chronic disease management and strengthen community-clinical linkages to existing services. We conducted an exploratory qualitative study using semistructured interviews and focus groups with PEs and people living with diabetes and/or hypertension. Interviews were recorded and conducted in Khmer script, transcribed and translated into the English language, and uploaded into Atlas.ti for analysis. We used a thematic analysis to identify key facilitators and barriers to disease management and opportunities for mHealth content and format. The information-motivation-behavioral model was used to guide data collection, analysis, and message development. We conducted six focus groups (N=59) and 11 interviews in one urban municipality and five rural operating districts from three provinces in October 2016. PE network participants desired mHealth to address barriers to chronic disease management through reminders about medications, laboratory tests and doctor's consultations, education on how to incorporate self-management into their daily lives, and support for obstacles to disease management. Participants preferred mobile-based voice messages to arrive at dinnertime for improved phone access and family support. They desired voice messages over texts to communicate trust and increase accessibility for persons with limited literacy, vision, and smartphone access. PEs shared similar views and perceived mHealth as acceptable and feasible for supporting their work. We developed 34 educational, supportive, and reminder mHealth messages based on these findings. These mHealth messages are currently being tested in a cluster randomized controlled trial (#1R21TW010160) to improve diabetes and hypertension control in Cambodia. This study has implications for practice and policies in Cambodia and other LMICs and low-resource US settings that are working to engage PEs and build community-clinical linkages to facilitate chronic disease management.
Linkhttp://doi.org/10.2196/13536
TitleA tele-pharmacy update.
AuthorsWertheimer, A
JournalThe International journal of pharmacy practice
Publication Date1 Jun 2019
Date Added to PubMed27 Apr 2019
Abstract
Linkhttp://doi.org/10.1111/ijpp.12523
TitleTelepharmacy for the management of cardiovascular patients in the community.
AuthorsOmboni, S; Tenti, M
JournalTrends in cardiovascular medicine
Publication Date1 Feb 2019
Date Added to PubMed25 Jul 2018
AbstractTelepharmacy is devised to provide pharmacy operations and patient care at a distance and to expand access to healthcare, enhance patients' safety and improve patient outcomes. A variety of technologies, models of care and interventions are used to develop and provide telepharmacy services, serving diversified populations with different pathological conditions, including cardiovascular diseases. Unfortunately, very few randomized controlled studies have evaluated the clinical efficacy of the implementation of telepharmacy services in the management of various cardiovascular conditions, with the strongest evidence being limited to telemonitoring studies in the areas of hypertension and diabetes. Although the clinical efficacy of telepharmacy, and its cost effectiveness, are far from being fully proved, the inclusion of telepharmacy services in healthcare models may offer the unique opportunity to increase access to screening and improve care of cardiovascular conditions.
Linkhttp://doi.org/10.1016/j.tcm.2018.07.002
TitleTelepharmacy: A Systematic Review of Field Application, Benefits, Limitations, and Applicability During the COVID-19 Pandemic.
AuthorsDat, TV; Tu, VL; Quan, NK; Minh, NH; Trung, TD; Le, TN; Phuc-Vinh, D; Trinh, DT; Pham Dinh, L; Nguyen-Thi, HY; Huy, NT
JournalTelemedicine journal and e-health : the official journal of the American Telemedicine Association
Publication Date1 Feb 2023
Date Added to PubMed28 Jun 2022
AbstractIntroduction: Telepharmacy is widely known as the delivery of pharmacy care offered by registered pharmacists and pharmacies using telecommunication technologies to patients at a distance. We conducted a systematic review of the reported usages, benefits, and limitations of telepharmacy models worldwide to further clarify the pros and cons of a telepharmacy model. Methods: A total of 39 relevant articles was included after searching for articles with a fixed term on four databases, including PubMed, Virtual Health Library (VHL), Global Health Library (GHL), and Google Scholar, as of April 2021. Results: Our review suggested that telepharmacy has played an essential role in addressing pharmacist shortages and helping patients both safely and effectively administer medications in underserved areas. During the COVID-19 pandemic, remote dispensing and counseling are effective measures to avoid infection. Conclusion: Telepharmacy could potentially replace or complement pharmaceutical-related activities, facilitating future innovation in the health care industry.
Linkhttp://doi.org/10.1089/tmj.2021.0575
TitleTelepharmacy in oncology care: A scoping review.
AuthorsVo, AT; Gustafson, DL
JournalJournal of telemedicine and telecare
Publication Date1 Apr 2023
Date Added to PubMed31 Dec 2020
AbstractTelepharmacy has the potential to enhance pharmacy services in oncology care, especially in remote areas. This scoping review explored the range, critical benefits and barriers of using telepharmacy services in oncology care. The scoping review followed the Arksey and O'Malley's five-stage framework to identify available evidence. PubMed, CINAHL, Embase, PsycINFO, Ovid MEDLINE and Scopus databases were searched for original research published between 2010 and 2020. The five dimensions of the Alberta Quality Matrix for Health were used to analyse reported outcomes. Eligible articles (n = 21) were analysed. Telepharmacy in oncology care was used for follow-up, monitoring and counselling, intravenous chemotherapy and sterile compounding, expanding availability of pharmacy services, and remote education. Telepharmacy obtained high acceptability among cancer patients (n = 5) and healthcare professionals (n = 5), and increased accessibility of pharmaceutical services to underserved cancer populations (n = 2). Commonly cited effectiveness and safety outcomes were improved patient adherence (n = 5), increased pharmacy services (n = 3) and early identification of medication-related problems (n = 5). Telepharmacy improved efficiency in staffing and workload (n = 3), and increased cost savings (n = 3). A shortage of resources (n = 5), technical problems (n = 4) and prolonged turnaround time (n = 4), safety concerns (n = 2) and patient willingness to pay (n = 1) were identified barriers to implementing telepharmacy in oncology care. Despite evidence pointing to the advantages and opportunities for expanding oncology pharmacy services through telepharmacy, certain challenges remain. Further research is needed to investigate safety concerns and patient willingness to pay for telepharmacy services.
Linkhttp://doi.org/10.1177/1357633X20975257
TitleTelepharmacy and pharmaceutical care: A narrative review by International Pharmaceutical Federation.
AuthorsViegas, R; Dineen-Griffin, S; Söderlund, LÅ; Acosta-Gómez, J; Maria Guiu, J
JournalFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Publication Date30 Oct 2022
Date Added to PubMed16 Dec 2022
AbstractDigital transformation impacts health care through technology. Telepharmacy is set to become one of the most important aspects of Telemedicine in the years  to come with its ability to provide patients with increased and more timely  access to pharmaceutical care, reduced costs for individuals and health  systems, improved patient satisfaction, experience and convenience, and  better health outcomes. Telepharmacy has gained increasing importance in the delivery of pharmaceutical care, largely due to the COVID-19 pandemic which  has placed enormous pressures on healthcare systems globally. There is a  significant amount of published literature from different countries around the  world that provide examples of Telepharmacy. There are some innovative  models of Telepharmacy services aimed at optimizing and improving access to  pharmaceutical care, resulting in improved patient safety and outcomes. The  benefits of Telepharmacy include increased value for pharmacies and  pharmacists and adapting to patients´ needs, enhanced interprofessional care  and increased efficiency of health systems and increased provision of patient- centred services, among others. However, despite these benefits, major  barriers for implementation of Telepharmacy remain such as patient  confidentiality and privacy of health information. These barriers to the  implementation of Telepharmacy have been identified and can be divided into  four different environments: technological, organizational, human and  economic. Delivering pharmaceutical care and services through digital media is identified as a key priority for the International Pharmaceutical Federation. Digital health is one of the 21 Development Goals launched by International Pharmaceutical Federation in 2020. The International Pharmaceutical Federation Digital Health in Pharmacy Education report in 2021, describes the  readiness, adaptability and responsiveness of pharmacy education and  knowledge and skill needs of pharmaceutical workforce on digital health.  Amongst other digital health tools, telehealth/Telepharmacy has been reported  as one of the most preferred tools to teach and learn about by respondents. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.ViegasRubénRInternational Pharmaceutical Federation, The Hague. rubenviegas23@gmail.com.Dineen-GriffinSarahSInternational Pharmaceutical Federation, The Hague. sarah.dineengriffin@newcastle.edu.au.SöderlundLars-ÅkeInternational Pharmaceutical Federation, The Hague. kpl547@hotmail.com.Acosta-GómezJaimeJInternational Pharmaceutical Federation, The Hague. j.acostapharm@gmail.com.Maria GuiuJosepJInternational Pharmaceutical Federation, The Hague. pepguiu@gmail.com.engReviewJournal ArticleTelefarmacia y atención farmacéutica: Una revisión narrativa de la Federación Internacional Farmacéutica.20221030SpainFarm Hosp94406791130-63430Pharmaceutical PreparationsIMHumansPandemicsPharmaceutical PreparationsCOVID-19InternetPharmaceutical ServicesTelemedicinePatient SatisfactionLa tecnología surgida de la transformación digital ha traído consigo cambios en la asistencia sanitaria. En los próximos años, la Telefarmacia previsiblemente  se convertirá en uno de los aspectos más importantes de la Telemedicina, ya  que ofrece a los pacientes un acceso más inmediato a la atención  farmacéutica, supone una reducción de costes tanto para los pacientes como  para los sistemas sanitarios, y deriva en una mayor satisfacción, experiencia y  comodidad de los pacientes, mejorando así los resultados clínicos. Debido en  gran medida a la pandemia de COVID‑19, la Telefarmacia ha adquirido gran  importancia en el ámbito de la atención farmacéutica, ya que esta crisis ha  provocado una enorme presión sobre los sistemas sanitarios de todo el mundo. Se pueden encontrar multitud de experiencias publicadas en la literatura  científica sobre modelos de Telefarmacia en diferentes países del mundo.  Existen algunos modelos innovadores de servicios de Telefarmacia orientados a  optimizar y mejorar el acceso a la atención farmacéutica, lo que se traduce  en una mejora de la seguridad y los resultados de los pacientes. Entre las  ventajas de la Telefarmacia se incluye el aumento del valor para las farmacias  y los farmacéuticos y la adaptación a las necesidades de los pacientes, la mejora de la atención interprofesional, el aumento de la eficiencia de los  sistemas sanitarios y la mayor prestación de servicios centrados en el paciente, entre otras. Sin embargo, a pesar de presentar múltiples ventajas, siguen  existiendo importantes barreras para la implantación de la Telefarmacia, como  la confidencialidad del paciente y la privacidad de la información clínica. Estas  barreras para la implantación de la Telefarmacia pueden dividirse en cuatro  ámbitos: tecnológico, organizativo, humano y económico. La prestación de  atención y servicios farmacéuticos a través de medios digitales es una  prioridad clave de la Federación Internacional Farmacéutica. La salud digital es  uno de los 21 Objetivos de Desarrollo lanzados por la Federación Internacional  Farmacéutica en 2020. El informe de la Federación Internacional Farmacéutica  sobre salud digital en la formación farmacéutica en 2021 describe la  preparación, adaptabilidad y capacidad de respuesta de la formación  farmacéutica y las necesidades de conocimientos y habilidades de los  farmacéuticos sobre la salud digital. Entre otras herramientas de salud digital,  la Telemedicina/Telefarmacia ha sido señalada como una de las herramientas  preferidas por los encuestados para formar y aprender.
Link
TitleTelepharmacy: A New Paradigm for Our Profession.
AuthorsLe, T; Toscani, M; Colaizzi, J
JournalJournal of pharmacy practice
Publication Date1 Apr 2020
Date Added to PubMed1 Aug 2018
AbstractTelepharmacy is a rapidly growing area of communication within pharmaceutical care delivery, especially in rural areas. The purpose of this literature review is to determine how telepharmacy is currently being practiced within community and ambulatory pharmacy settings, its effectiveness, and how it is being regulated across the United States. A literature review was performed using PubMed, Ovid MEDLINE, and the Google search engine. State-specific rules were researched using board of pharmacy and legislative online resources. Telepharmacy has been successfully implemented within community pharmacy settings through the creation of remote dispensing sites. The increasing focus of state regulations on telepharmacy services and practices shows the growth and acceptance of this modality of pharmacy practice. There is wide variation among state regulations pertaining to the setup and operation of telepharmacies. Trends in telemedicine show that telepharmaceutical care is likely to continue to expand as it allows for a better allocation of resources and access to more patients. However, research needs to be conducted to specifically analyze the value and place for telepharmacy services.
Linkhttp://doi.org/10.1177/0897190018791060
MNCHFPRHHIV/AIDSMalariaNoncommunicable diseaseCOVID-19Decision-makingEducation & trainingBehavior changeGovernancePrivacy & securityEquityCHWsYouth & adolescentsSystematic reviewsProtocols & research designMedical RecordsLaboratoryPharmacyHuman ResourcesmHealthSMSChatbotsAI